Text and Data Mining valid from 2019-12-01
Received: 22 June 2019
Accepted: 12 November 2019
First Online: 2 December 2019
Ethics approval and consent to participate
: Not Applicable.
: The patient provided full consent for participation and publication.
: Solange Peters has received education grants, provided consultation, attended advisory boards, and/or provided lectures for: Abbvie, Amgen, AstraZeneca, Bayer, Biocartis, Bioinvent, Blueprint Medicines, Boehringer-Ingelheim, Bristol-Myers Squibb, Clovis, Daiichi Sankyo, Debiopharm, Eli Lilly, F. Hoffmann-La Roche, Foundation Medicine, Illumina, Incyte, Janssen, Merck Sharp and Dohme, Merck Serono, Merrimack, Novartis, Pharma Mar, Pfizer, Regeneron, Sanofi, Seattle Genetics and Takeda, from whom she has received honoraria (fees to institution). The remaining authors declare that they have no competing interests.